601 related articles for article (PubMed ID: 16740715)
41. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells.
Edqvist A; Rebetz J; Järås M; Rydelius A; Skagerberg G; Salford LG; Widegren B; Fan X
Mol Ther; 2006 Jul; 14(1):139-48. PubMed ID: 16584924
[TBL] [Abstract][Full Text] [Related]
42. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
43. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
[TBL] [Abstract][Full Text] [Related]
44. [Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line].
Cheng W; Su Y; Ma HQ; Wei ZF; Gao JP; Zhang ZY; Ge JP; Jing KZ; Xu F
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2847-52. PubMed ID: 20137667
[TBL] [Abstract][Full Text] [Related]
45. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
[TBL] [Abstract][Full Text] [Related]
46. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
[TBL] [Abstract][Full Text] [Related]
47. Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNA.
Marie-Egyptienne DT; Brault ME; Nimmo GA; Londoño-Vallejo JA; Autexier C
Cancer Lett; 2009 Mar; 275(2):266-76. PubMed ID: 19056167
[TBL] [Abstract][Full Text] [Related]
48. A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation.
Marie-Egyptienne DT; Cerone MA; Londoño-Vallejo JA; Autexier C
Nucleic Acids Res; 2005; 33(17):5446-57. PubMed ID: 16192571
[TBL] [Abstract][Full Text] [Related]
49. Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.
Cerone MA; Londoño-Vallejo JA; Autexier C
Oncogene; 2006 Nov; 25(56):7411-20. PubMed ID: 16767163
[TBL] [Abstract][Full Text] [Related]
50. [Study on apoptosis of human cervical carcinoma HeLa cells with RNA interference targeting hTERT].
Zhao Y; Ren JL; Zhang R; Ma LY; Bao W; Wang CJ; Yang AG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):524-6. PubMed ID: 15989808
[TBL] [Abstract][Full Text] [Related]
51. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
52. [A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3].
Lu XD; Qin WX; Pan DN; Li JJ; Wan DF; Wen CJ; Li CJ; Gu JR; Yang SL
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1381-5. PubMed ID: 15387948
[TBL] [Abstract][Full Text] [Related]
53. Telomerase, checkpoints and cancer.
Harley CB; Sherwood SW
Cancer Surv; 1997; 29():263-84. PubMed ID: 9338104
[TBL] [Abstract][Full Text] [Related]
54. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
[TBL] [Abstract][Full Text] [Related]
55. hTERT associates with human telomeres and enhances genomic stability and DNA repair.
Sharma GG; Gupta A; Wang H; Scherthan H; Dhar S; Gandhi V; Iliakis G; Shay JW; Young CS; Pandita TK
Oncogene; 2003 Jan; 22(1):131-46. PubMed ID: 12527915
[TBL] [Abstract][Full Text] [Related]
56. A mutant telomerase defective in nuclear-cytoplasmic shuttling fails to immortalize cells and is associated with mitochondrial dysfunction.
Kovalenko OA; Caron MJ; Ulema P; Medrano C; Thomas AP; Kimura M; Bonini MG; Herbig U; Santos JH
Aging Cell; 2010 Apr; 9(2):203-19. PubMed ID: 20089117
[TBL] [Abstract][Full Text] [Related]
57. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
El Daly H; Martens UM
Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
[TBL] [Abstract][Full Text] [Related]
58. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells.
Compton SA; Choi JH; Cesare AJ; Ozgür S; Griffith JD
Cancer Res; 2007 Feb; 67(4):1513-9. PubMed ID: 17308089
[TBL] [Abstract][Full Text] [Related]
59. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
60. shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Cancer Chemother Pharmacol; 2006 Feb; 57(3):328-34. PubMed ID: 16028098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
